Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Squamous Carcinoma Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05174325
What this trial is testing

Effectiveness of Neoadjuvant Chemotherapy Combined With PD-1 Monoclonal Antibody in the Treatment of Operable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Soochow University 30
Not applicableUnknownNCT06478355
What this trial is testing

Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR）

Who this might be right for
ESCC
Hebei Medical University Fourth Hospital 800
Testing effectiveness (Phase 2)UnknownNCT02353936
What this trial is testing

A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus

Who this might be right for
Squamous Cell Carcinoma of Esophagus
Yonsei University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06885814
What this trial is testing

Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Nanfang Hospital, Southern Medical University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06746961
What this trial is testing

Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs Therapy

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
The First Affiliated Hospital of Zhengzhou University 49
Early research (Phase 1)Ended earlyNCT05462873
What this trial is testing

Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellEsophageal Squamous Cell Carcinoma+1 more
Novartis Pharmaceuticals 30
Testing effectiveness (Phase 2)UnknownNCT03185988
What this trial is testing

Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System

Who this might be right for
Targeted TherapyHER2Biliary Tract Cancer+2 more
Shen Lin 100
Testing effectiveness (Phase 2)Study completedNCT03904927
What this trial is testing

Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma
Fudan University 104
Not applicableUnknownNCT01837173
What this trial is testing

Multicentric Retrospective Review of Extracapsular Lymph Node Involvement After Esophagectomy

Who this might be right for
Cancer
University Hospital, Gasthuisberg 2,000
Not applicableStudy completedNCT04609813
What this trial is testing

Esophageal cAncer Screening Trial

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal CancerGastroesophageal Junction Adenocarcinoma
Changhai Hospital 14,597
Testing effectiveness (Phase 2)Looking for participantsNCT06769113
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy

Who this might be right for
Esophageal Cancer
Shanghai Henlius Biotech 102
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07709533
What this trial is testing

An Umbrella-designed Prospective Multicenter Randomized Open-label Superiority Trial Evaluating Multi-biomarker-guided Precision Therapy for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Valid MeSH Conditions
Sun Yat-sen University 347
Testing effectiveness (Phase 2)UnknownNCT03224221
What this trial is testing

Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Anhui Medical University 189
Testing effectiveness (Phase 2)Study completedNCT03797625
What this trial is testing

Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 52
Testing effectiveness (Phase 2)Looking for participantsNCT06421376
What this trial is testing

Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Esophageal CancerImmunotherapyInduction Therapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Not applicableStudy completedNCT03937362
What this trial is testing

Pre-Surgery If Needed for Oesophageal Cancer

Who this might be right for
Esophageal Cancer
Shanghai Chest Hospital 200
Not applicableLooking for participantsNCT04519905
What this trial is testing

Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)

Who this might be right for
Esophageal Squamous Cell CarcinomaChemoradiotherapySurvival
Fudan University 320
Not applicableUnknownNCT04759235
What this trial is testing

Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
RenJi Hospital 118
Testing effectiveness (Phase 2)Ended earlyNCT00503776
What this trial is testing

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Who this might be right for
DysphagiaHead and Neck CancerMucositis+1 more
Vanderbilt-Ingram Cancer Center 41
Large-scale testing (Phase 3)Study completedNCT03933449
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension Study

Who this might be right for
Esophageal CarcinomaEsophagogastric Junction Carcinoma
Merck Sharp & Dohme LLC 123
Next Page